Skip to content

Long and short term effects of Matrixstimulation in cancer pain.

Long and short term effects of Matrixstimulation in cancer pain.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009614
Enrollment
20
Registered
2016-06-27
Start date
2014-01-03
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain (pancreas, lung cancer ...) R52.1

Interventions

Group 1: Patient with cancer pain, Matrixstimulation, 4 Hz, 5 Minutes, Stimulation twice a day (morning and evening) on three consecutive days (day 1-3).

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria was a minimum age of 18 years and a written consent after a detailed explanation of the investigation, Cancer pain

Exclusion criteria

Exclusion criteria: Exclusion criteria were contraindications to the use of electrical stimulation such as the presence of cardiac pacemakers or other implanted electronic devices, severe cardiac arrhythmia, osteosyntheses, malignant tumors, neurological diseases, peripheral vascular diseases, pregnancy, breastfeeding women, haemophilia, skin or soft tissue disease or chronic pain syndromes such as migraine or back pain. Previous experience with electrical stimulation methods was also an exclusion criteria inorder to avoid an expectation bia

Design outcomes

Primary

MeasureTime frame
Leads the Matrixstimulation to a significant pain reduction compared to Baseline? Rating carried out in accordance of the Numeric Rating Scale (NRS)

Secondary

MeasureTime frame
Reduction of on demand medication during follow-up (day 4-7). On demand opioid drug use will be converted into an oral morphine equivalent (OME) for ease of comparison (Baseline, Therapy, Follow-up).

Countries

Germany

Contacts

Public ContactMartin Mücke

Klinik und Poliklinik für PalliativmedizinUniversitätsklinikum Bonn

muecke@uni-bonn.de0228 287 16361

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026